A single centre, double-blind, randomized controlled trial investigating repetitive transcranial magnetic stimulation (rTMS) to treat persistent post-concussion symptoms in children

Associate Professor Karen Barlow0 个研究点目标入组 54 人开始时间: 2019年8月12日最近更新: 2019年8月26日

试验速览

暂无简介。

•1.Male or female, 11-18 years of age inclusive (at time of initial pre-screening), currently experiencing post concussive symptoms.
•2.Documentation of persistent post concussive symptoms as evidenced by two or more clinical symptoms: headache, difficulty concentrating or remembering, sleep problems, dizziness, fatigue or nausea/vomiting – not explained by another disorder.
•3.Post concussive symptoms for more than/equal to 2 months.
•4.No history of rTMS treatments.

•1.Epilepsy or other seizure disorders.
•2.Chronic treatment with psychotropic medication or any other medications deemed unsuitable for TMS application as deemed by the Investigator.
•3.Neurological disorders, including moderate to severe learning difficulties.
•4.Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
•5.Females of child-bearing potential only: Pregnant as confirmed by urine pregnancy test at baseline visit; and unwillingness to use contraception from pre-screening to follow-up visit (if sexually active); currently breastfeeding.
•6.No recreational drug use.

发起方

Associate Professor Karen Barlow